APPLICATIONS PUBLISHED 2 APRIL 2003

Published: 1-Sep-2003

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492

  • Antisense modulation of transforming growth factor-beta expression
    Isis Pharmaceuticals 1296643*

  • Systems and methods for treating a mucosal surface
    3M Innovative Properties 1296644*

  • Methods for treating inflammation-mediated conditions of the eye
    Oculex Pharmaceuticals 1296645*

  • Oral pharmaceutical compsns containing terbinafine
    Novartis 1296646*

  • Polymeric micelle compsns
    Labopharm 1296647*

  • Micellar pharmaceutical compsns for buccal and pulmonary application
    Generex Pharmaceuticals 1296648*

  • Pharmaceutical compsns comprising an opioid analgesic
    Pharmasol 1296649*

  • Methods and compsns for treating pain of the mucous membrane
    EpiCept 1296650*

  • Method for making particles of use in a pharmaceutical compsn
    Vectura 1296651*

  • Topical pharmaceutical formulation and methods of treatment
    Vectura 1296652*

  • Method for formulating healthcare products with enhanced stability
    Deisys Pharmaceutical 1296653*

  • Use of dicalcium phosphate anhydrous powder
    Chemische Fabrik Budenheim 1296654*

  • Endoparasiticidal agens for voluntary oral ingestion by animals
    Bayer 1296655*

  • Method for preparing a compsn
    F Hoffmann-La Roche 1296656*

  • Compsn and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
    Teva Pharmaceutical Industries 1296657*

  • Use of an acetylated pre-gelled starch with a high content of amylose
    FT Holdings 1296658*

  • Pharmaceutical compsns of 2'-deoxy-2'-(fluoromethylene)cytidine
    Matrix Pharmaceutical 1296659*

  • The controlled release preparation of insulin and its method
    Mi Tech Company 1296660*

  • Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities
    LTS Lohmann Therapie-Systeme 1296661*

  • Dermal therapeutic system containing 2-(3-benzophenyl)-propionic acid or '0-(2,6-dichloroanilino)-phenyl-ethanoic acid
    Labtec Gesellschaft fuer Technologische Forschung und Entwicklung 1296662*

  • Highly effective delivery of a large therapeutic mass aerosol
    Advanced Inhalation Research 1296663*

  • Propofol for treatment of sepsis
    AstraZeneca 1296664*

  • Analgesic and anti-inflammatory compsns containing COX-2 inhibitors
    Wyeth 1296665*

  • Improved thyroid hormone formulations
    Deisys Pharmaceuticals 1296666*

  • Use of an aluminium and ethylenediamine-tetraacetic complex for preventing and/or treating urticaria
    Mayer, Marie-Claude 1296667*

  • Compsns based on aminoacids, suitable for improving muscle performance
    Professional Dietetics 1296668*

  • Combination preparation consisting of (v)-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs
    Fresenius Kabi Deutschland 1296669*

  • Therapeutic combinations of fatty acids
    Laxdale Ltd 1296670*

  • Gabapentin analogues for sleep disorders
    Warner-Lambert 1296671*

  • Stable pharmaceutical product and formulation
    LEK Pharmaceuticals 1296672*

  • Antimicrobial coatings
    Unsearch Ltd 1296673*

  • Use of substituted indole compounds for increasing nitric oxide synthase activity
    Wyeth 1296674*

  • Compsns based on amino acids, suitable for the treatment of heart failure
    Professional Dietetics 1296675*

  • Use of indole-3-acetic acid derivatives in medicine
    Cancer Research Technology 1296676*

  • Solid valsartan pharmaceutical compsns
    Novartis 1296677*

  • Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
    DuPont Pharmaceuticals 1296678*

  • Dermal therapeutic system containing non-steroidal antiphlogistics with selective COX-2 inhibition
    LTS Lohmann Therapie-Systeme 1296679*

  • The method of treating drug resistant mycobacterium tuberculosis infection
    Khamar, Bakulesh Mafatlal 1296680*

  • Use of microsomal triglyceride transfer protein (MTP) inhibitors, for reducing the number of post-prandial triglyceride-rich lipoprotein particles (PPTRL)
    Bayer 1296681*

  • Chemosensitiser
    Khamar, Bakulash Mafatlal 1296682*

  • Methods of treating neutrophil-related diseases with topical anaethetics
    Mayo Foundation for Medical Education and Research 1296683*

  • Treatment of gastroesophageal reflux disease using piperidine derivatives
    ARYx Therapeutics 1296684*

  • Sustained-release preparations of quinolone antibiotics and method for preparation thereof
    Bayer 1296685*

  • You may also like